Vitamine D supply in girls of puberty age with autoimmune hepatitis
DOI:
https://doi.org/10.12775/JEHS.2020.10.05.039Keywords
girls, puberty age, autoimmune hepatitis, vitamin D supplyAbstract
Vitamin D undergoes important biotransformation and inactivation in the liver. Because vitamin D is metabolized in the liver, abnormal vitamin D metabolism can be expected to be associated with chronic liver disease, including autoimmune hepatitis (AIH). The prevalence of vitamin D deficiency in puberty was the justification for the objective of the study– to determine the characteristics of vitamin D supply in girls of puberty age with AIH with autoimmune hepatitis during this period. Materials and methods. To solve this goal, a comprehensive clinical and paraclinical examination of 66 girls withAIH and 180 relatively healthy girls of the control group aged 12-17 years. The complex included clinical and anamnestic data, biochemical study of liver function, determination of serum autoantibodies and markers of viral hepatitis, the level of 25- (OH) D in blood serum, ultrasound and elastography of the hepatobiliary system organs, liver biopsy. Results. The mean level of vitamin 25 (OH) D in the serum of girls with AIH of pubertal age was 17.14 ± 1.06 vs. 23.27 ± 0.53 ng / ml in the control (p<0,01). In 66.67% of patients with AIH there was a deficiency of 25 (OH) D, in 22.73% – insufficiency, in 10.61% – the optimal level. The supply of vitamin D depended on the histological activity of AIG. Among girls with AIH and histological activity index> 9 points, the share of patients with vitamin D deficiency was 79.41% compared with 53.13% of cases among girls with AIH, where the histological activity index was <9 points (χ2=5.13; p<0,02). Conclusions. Cytolysis, cholestasis, mesenchymal-inflammatory syndrome, hepatocellular insufficiency in AIH in girls of puberty agedevelops against the background of reduced vitamin D supply, which depends on the histological activity of the disease.
References
Agmon-Levin N, Kopilov R, Selmi C, Nussinovitch U, Sánchez-Castañón M, López-Hoyos M, et al. Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease. Immunol Res. 2015 Feb;61(1-2):141-6. doi: 10.1007/s12026-014-8594-0.
Antico A., Tampoia M., Tozzoli R., Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmunity Reviews. 2012;12(2):127–136. doi: 10.1016/j.autrev.2012.07.007.
Baranov AA, Namazova-Baranova LS, Gundobina OS, Gorelov AV. Federal clinical guidelines for the provision of medical care to children with autoimmune hepatitis. Moscow, 2015.18 p. (in Russian)
Bedossa, P., Poynard, T., and The METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996; 24: 289 – 293.
Berezenko VS, Mikhailyuk HZ, Shadrin VO, Krat VV. Features of vitamin D supplementation in children with autoimmune hepatitis. Perinatology and pediatrics.2018;1(73):92-97 (in Ukrainian).
Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017 Nov 3;11(11):CD011564. doi: 10.1002/14651858.CD011564.pub2.
Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016 Apr;103(4):1033-44. doi: 10.3945/ajcn.115.120873.
Castera L. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2015; 35(03): 291-303. DOI: 10.1055/s-0035-1562948.
Cepero-Donates Y, Rakotoarivelo V, Mayhue M, Ma A, Chen Y-G, Ramanathan S. Homeostasis of IL-15 dependent lymphocyte subsets in the liver. Cytokine. 2016;82:95–101. doi: 10.1016/j.cyto.2015.12.012.
Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, Sun J, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol. 2011 Dec 15;187(12):6335-45. doi: 10.4049/jimmunol.1003965.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30. doi: 10.1210/jc.2011-0385.
Jimenez-Rivera C, Hadjiyannakis S, Davila J, Hurteau J, Aglipay M, Barrowman N, Adamo KB. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. BMC Pediatr. 2017 Apr 26;17(1):113. doi: 10.1186/s12887-017-0867-z.
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–55.
Kumar V. NKT-cell subsets: promoters and protectors in inflammatory liver disease. Journal of Hepatology. 2013;59(3):618–620. doi: 10.1016/j.jhep. 2013.02.032.
Liberal R, Vergani D, Mieli-Vergani G. Update on Autoimmune Hepatitis. J Clin Transl Hepatol. 2015 Mar;3(1):42-52. doi: 10.14218/JCTH.2014.00032.
Mattner J. Natural killer T (NKT) cells in autoimmune hepatitis. Current Opinion in Immunology. 2013;25(6):697–703. doi: 10.1016/j.coi.2013.09.008. 19
Mesova AM, Seksenbaeva RE. Autoimmune hepatitis in children. KazNMU Bulletin. 2016;3;1-4.
Reiter FP, Hohenester S, Nagel JM, Wimmer R, Artmann R, Wottke L, et al. 1,25-(OH)(2)-vitamin D(3) prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model. Biochemical and Biophysical Research Communications. 2015 April 3;459(2):227–233. doi: 10.1016/j.bbrc.2015.02.074.
Saggese G, Vierucci F, Prodam F, Cardinale F, Cetin I, Chiappini E, et al. Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians. Ital J Pediatr. 2018 May 8;44(1):51. doi: 10.1186/s13052-018-0488-7.
Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmunity Reviews. 2011;10(12):793–800. doi: 10.1016/j.autrev.2011.06.003.
Sciveres M, Nastasio S, Maggiore G. Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis. Front Pediatr. 2019 Sep 20;7:382. doi: 10.3389/fped.2019.00382.
Smyk DS, Mavropoulos A, Mieli-Vergani G, Vergani D, Lenzi M, Bogdanos DP. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator? Can J Gastroenterol Hepatol. 2018 Jun 26;2018:8197937. doi: 10.1155/2018/81979376.
Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clinics and Research in Hepatology and Gastroenterology. 2013;37(5):535–545. doi: 10.1016/j.clinre.2013.05.016.
Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res. 2019 Nov 25;2019:9437043. doi: 10.1155/2019/9437043.
Swain MG. Hepatic NKT cells: Friend or foe? Clinical Science. 2008;114(7):457–466. doi: 10.1042/CS20070328.
Tasneem AA, Luck NH. Autoimmune Hepatitis: Clinical Characteristics and Predictors of Biochemical Response to Treatment. J Transl Int Med. 2020 Jun 30;8(2):106-111. doi: 10.2478/jtim-2020-0016.
Uchaikin V.F. Guide to Infectious Diseases in Children. Moscow: GEOTAR MEDICINA, 1998: 809 p.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 419
Number of citations: 0